Menveo (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the Menveo drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
| NON-PROPRIETARY NAME: | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
| SUBSTANCE NAME: | |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Menveo VACCINE Details:
| Item Description | Menveo from GlaxoSmithKline Biologicals SA |
| LABELER NAME: | GlaxoSmithKline Biologicals SA |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58160-955_d3112765-d061-4d4b-9444-b0e1f27e4e03 |
| PRODUCT NDC: | 58160-955 |
| APPLICATION NUMBER: | BLA125300 |